Page 8 - Factory Mutual News Today

Styrofoam™ Brand XPS Insulation Introduces a Reduced GWP Formulation for Greater Sustainability Share Article January 1, 2021, marked a significant transition for DuPonts Styrofoam™ Brand Extruded Polystyrene Foam Insulation, with the new reduced global warming potential product line now available for specification and sale in Canada. “We know that sustainability is more than just how our products are produced. Sustainability is also about how they perform,” says Jeff Hansbro, Global Ad...

Fire prevention tips to keep in mind this winter Fire prevention tips to keep in mind this winter By Melissa Rademaker | January 5, 2021 at 6:03 PM CST - Updated January 5 at 6:05 PM JONES COUNTY, Miss. (WDAM) - Fire departments in Jones County are already having a busy year putting out structure fires. Just five days into the new year, firefighters have already responded to four structure fires. “Once that smoke detector goes off, you have a matter of minutes to escape,” Glade Fire an...

Cinemark sues insurer over COVID-related losses There have been more than 1,300 other lawsuits filed against insurers who refused to pay claims on business-interruption policies. Cinemark said it paid $3,785,253 in premiums for a one-year, all-risk policy that expired April 20.(Irwin Thompson) Plano-based movie theater operator Cinemark Holdings Inc. sued its insurer this week for refusing to cover $400 million in losses and legal expenses linked to the coronavirus pandemic. The third-biggest U...

April 16, 2021 With the launch of the Gambling Act review dominating the betting industry’s agenda last week, Regulus Partners observed that initial reactions suggest the government debate is off to a good start. Can betting remain on the government’s good list this year, or will the festive spirit be short-lived? UK: In Parliament – the Great British Gambling Act Review – off to a good start Perhaps it was the spirit of the season but this week’s parliamentary debates on the Gambling...

by RBC Capital Markets Gilead Sciences announced the acquisition of MYR Pharmaceuticals, a German biotech whose lead drug is for hepatitis delta (an occasional co-infection with hepatitis B), for $1.4 billion and a $360 million milestone payment contingent on FDA approval. Coming on the heels of the transformative Immunomedics deal, we believe that this shows management’s continued willingness to leverage the balance sheet to bring in synergistic assets. Unlike Immunomedics, though, tod...

MLB Sues Insurers Over Billions in Pandemic-Related Losses Mark Brown/Getty Images The league claims its facing "catastrophic economic losses" after it was forced to cancel more than 1,500 games — and play the ones that werent canceled in empty stadiums. The COVID-19 pandemic has sparked a wave of litigation against insurance companies for denying coronavirus-related claims and, in one of the latest suits, Major League Baseball is swinging for the fences in claiming more than a billion dollar...